Αποτελέσματα Αναζήτησης
9 Οκτ 2024 · Peri-procedural Anticoagulation Guidelines. 1. Determine procedure bleeding risk (low or high; see Bleeding Risk Categorization below) 2. Determine needed labs and Platelet/INR goals (see Laboratory Values below). 3. Refer to anticoagulation guidelines based on procedure risk category (see Management of Medications below).
29 Οκτ 2024 · COVID-19 Resources. Phone numbers: COVID Hotline: 385-0429; Employee/Occupational Health: 684-8115; Departmental Policies. Diagnostic Infection Prevention: File:Diagnostic InfectionPreventionGuidance Radiology COVID-19.pdf Procedural Infection Prevention: File:Procedural InfectionPreventiononGuidance Radiology COVID-19.pdf PPE Guidelines: File:PPE Guidelines Radiology COVID-19.pdf
19 Νοε 2024 · 3 Duke Inpatient Floors. 3.1 Duke North; 3.2 DMP; 3.3 Duke Central Tower; 4 Reading Rooms; 5 CT Scanners/Techs. ... Please do not use Epic Chat or pagers to relay ED patient results. Charge Nurse 681-4410 Flow Nurse 684-4705 ... Outside Interpretation 684-7274 Phone Numbers: General Numbers Candie Stewart 668-7221 Code Blue 115 3D Lab
Once your ultrasound is complete, your images are interpreted by a radiologist, a doctor trained in medical image interpretation. Your report and images will be available through My Duke Health for you to discuss with your doctor.
23 Δεκ 2020 · All simple and nonsimple cysts smaller than 10 cm are considered O-RADS 2, and management is based on lesion size and menopausal status. When the cyst measures 10 cm or larger, O-RADS 3 assessment is rendered, and evaluation by an US specialist or with an MRI study should be considered.
This guide provides an overview of ultrasound exams, including the types of examinations available, what patients can expect during the exam and how to interpret ultrasound results. Ultrasound imaging typically does not require any sort of sedation or radiation exposure.
4 Μαΐ 2021 · Following the results of the descriptive statistics and the multivariate regression, we developed a new clinical decision rule for determining whether a patient should be classified as BI-RADS 3 (undergo follow-up imaging) or as BI-RADS 4 (undergo biopsy).
